Xenon Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell XENE and other ETFs, options, and stocks.

About XENE

Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions.

CEO

Ian C. Mortimer

CEOIan C. Mortimer

Employees

327

Employees327

Headquarters

Burnaby, British Columbia

HeadquartersBurnaby, British Columbia

Founded

1996

Founded1996

Employees

327

Employees327

XENE Key Statistics

Market cap

2.88B

Market cap2.88B

Price-Earnings ratio

-12.51

Price-Earnings ratio-12.51

Dividend yield

—

Dividend yield—

Average volume

723.79K

Average volume723.79K

High today

$38.51

High today$38.51

Low today

$37.38

Low today$37.38

Open price

$38.05

Open price$38.05

Volume

418.10K

Volume418.10K

52 Week high

$46.00

52 Week high$46.00

52 Week low

$26.74

52 Week low$26.74

Analyst ratings

100%

of 17 ratings

Buy

100%

Hold

Sell

Xenon Pharmaceuticals

Why Robinhood?

Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. Show more

XENE Key Statistics

Analyst ratings

100%

Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions.